Related Experiment Video
Updated: Aug 3, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
Structure-Selectivity Relationship Prediction of Tau Imaging Tracers Using Machine Learning-Assisted QSAR Models and
Maryam Gholampour1, Hassan Seradj1, Amirhossein Sakhteman2
1Department of Medicinal Chemistry, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz 71468-64685, Iran.
Computational methods reveal key molecular features for selective tau imaging agents. Understanding these structural properties aids in designing better positron emission tomography tracers for tauopathies.
Area of Science:
- Neuroscience
- Computational Chemistry
- Pharmacology
Background:
- Tau fibrils are key pathological hallmarks in tauopathies.
- Current imaging agents lack well-understood molecular binding mechanisms.
- Highly selective agents are needed for accurate tau imaging.
Purpose of the Study:
- Investigate the structural basis of selective tau aggregate binding.
- Identify essential molecular moieties for selective binding.
- Facilitate rational design of novel tau imaging agents.
Main Methods:
- Machine learning-based quantitative structure-activity relationship (QSAR) classification.
- Molecular docking and molecular dynamics (MD) simulations.
- MM/PBSA binding free-energy calculations.
Main Results:
- A Random Forest QSAR model achieved high accuracy (96.6% selective, 97.6% non-selective).
- Ligand 63 demonstrated superior binding energy to tau and PHF6.
- Key selective moieties include N-heterocycles, nitrogen atom positions, and tertiary amines.
Conclusions:
- Computational approaches elucidate the structure-selectivity relationship for tau binding.
- Identified molecular features are crucial for designing selective tau imaging agents.
- This knowledge will guide the development of improved positron emission tomography tracers.
More Related Videos
09:49In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
Published on: November 20, 2018
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018